通过抗体-抗体相互作用对肝炎E病毒的协同中和的结构基础
Minghua Zheng1,2, Lizhi Zhou1,2, Yang Huang1,2
1State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Department of Laboratory Medicine, School of Public Health, School of Life Sciences, Xiamen University, Xiamen 361102, China.
两种E型肝炎病毒中和抗体 (nAbs) 显示出协同作用,增强中和. 结构分析揭示了一种单向协同机制,这对于设计有效的抗体尾酒至关重要.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 结构生物学 结构生物学
背景情况:
- 中和抗体 (nAbs) 对于抗病毒疗法和疫苗开发至关重要.
- 肝炎E病毒 (HEV) 感染对全球健康构成重大挑战.
- 了解nAb的相互作用是改善抗病毒策略的关键.
研究的目的:
- 为了研究两个HEV nAbs,8H3和8C11.的协同中和作用.
- 阐明它们协同或对抗相互作用的结构基础.
- 探索一种设计协同抗体尾酒的新策略.
主要方法:
- 用X射线晶体学来确定抗体-抗原复合物的结构.
- 位点定向的突变发生,以确定关键结合残留物.
- 分子动力学模拟用于分析抗体-抗体相互作用.
- 基于HEV的细胞模型来评估中和活性.
主要成果:
- 该研究揭示了HEV nAbs 8H3和8C11之间的单向协同效应,这取决于结合的顺序.
- 晶体结构确定了特定的结合足迹和关键残留物 (例如,Ile 529),参与了协同作用.
- 综合抗体方法证明了增强的物理干扰和HEV的强有力的控制.
- 当绑定顺序被逆转时,观察到一个对抗性的效应.
结论:
- 抗体结合的序列决定了协同作用或对抗作用的相互作用.
- 529是8H3和8C11之间协同作用的关键残留物.
- 这项研究为设计针对HEV的有效协同抗体尾酒提供了框架.
更多相关视频
07:52Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
Published on: September 10, 2018
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
相关概念视频
01:26Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
01:29Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:41Affinity and Avidity
00:42Cross-reactivity